Lv11
70 积分 2025-03-25 加入
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus
5小时前
已完结
CD303 (BDCA-2) – a potential novel target for therapy in hematologic malignancies
5小时前
已完结
An Overview of Emerging Trends and Technologies in Ulcerative Colitis
1个月前
已完结
An Overview of Emerging Trends and Technologies in Ulcerative Colitis
1个月前
已完结
[Intestinal fibrosis in Crohn's disease : towards new therapeutic options?]
1个月前
已关闭
Antibodies targeting the tumor necrosis factor (TNF) -like ligand 1A (TL1A) in Inflammatory Bowel Disease – a new kid on the (biologics) block?
1个月前
已完结
TL1A as a therapeutic target in inflammatory bowel disease
1个月前
已完结
Strategies for targeting cytokines in inflammatory bowel disease
1个月前
已完结
皖公网安备34019202002308
